These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 17300876

  • 1. Mechanism of Phosphodiesterase 5 inhibitor relief of prostatitis symptoms.
    Grimsley SJ, Khan MH, Jones GE.
    Med Hypotheses; 2007; 69(1):25-6. PubMed ID: 17300876
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Systemic approach to investigation of levitra efficacy in patients with chronic prostatitis with erectile dysfunction].
    Aliaev IuG, Ronkin MA, Esilevskiĭ IuM, Zhuchenko TD, Demidko IuL, Krupinov GE, Shcherbanina VIu.
    Urologiia; 2005; (2):53-60. PubMed ID: 15989030
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms.
    Tinel H, Stelte-Ludwig B, Hütter J, Sandner P.
    BJU Int; 2006 Dec; 98(6):1259-63. PubMed ID: 16956354
    [Abstract] [Full Text] [Related]

  • 7. Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue.
    Uckert S, Sormes M, Kedia G, Scheller F, Knapp WH, Jonas U, Stief CG.
    Urology; 2008 Mar; 71(3):526-30. PubMed ID: 18342202
    [Abstract] [Full Text] [Related]

  • 8. A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization.
    Blount MA, Zoraghi R, Ke H, Bessay EP, Corbin JD, Francis SH.
    Mol Pharmacol; 2006 Nov; 70(5):1822-31. PubMed ID: 16926278
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Emergence and success of PDE5 inhibitors as effective therapy for erectile dysfunction.
    Manganiello V.
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S1-3. PubMed ID: 15224126
    [No Abstract] [Full Text] [Related]

  • 12. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy.
    Salonia A, Gallina A, Zanni G, Briganti A, Dehò F, Saccà A, Suardi N, Barbieri L, Guazzoni G, Rigatti P, Montorsi F.
    Eur Urol; 2008 Mar; 53(3):564-70. PubMed ID: 17761385
    [Abstract] [Full Text] [Related]

  • 13. Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction.
    Shabsigh R, Seftel AD, Rosen RC, Porst H, Ahuja S, Deeley MC, Garcia CS, Giuliano F.
    Urology; 2006 Oct; 68(4):689-96. PubMed ID: 17070333
    [No Abstract] [Full Text] [Related]

  • 14. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
    Ravipati G, McClung JA, Aronow WS, Peterson SJ, Frishman WH.
    Cardiol Rev; 2007 Oct; 15(2):76-86. PubMed ID: 17303994
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High lung PDE5: a strong basis for treating pulmonary hypertension with PDE5 inhibitors.
    Corbin JD, Beasley A, Blount MA, Francis SH.
    Biochem Biophys Res Commun; 2005 Sep 02; 334(3):930-8. PubMed ID: 16023993
    [Abstract] [Full Text] [Related]

  • 18. 3D-QSAR studies on sildenafil analogues, selective phosphodiesterase 5 inhibitors.
    Yoo J, Thai KM, Kim DK, Lee JY, Park HJ.
    Bioorg Med Chem Lett; 2007 Aug 01; 17(15):4271-4. PubMed ID: 17553682
    [Abstract] [Full Text] [Related]

  • 19. Phosphodiesterase inhibitors in Raynaud's phenomenon.
    Levien TL.
    Ann Pharmacother; 2006 Aug 01; 40(7-8):1388-93. PubMed ID: 16835313
    [Abstract] [Full Text] [Related]

  • 20. Low-dose phosphodiesterase inhibition improves responsiveness to inhaled nitric oxide in isolated lungs from endotoxemic rats.
    Klein A, Zils U, Bopp C, Gries A, Martin E, Gust R.
    J Surg Res; 2007 Apr 01; 138(2):224-30. PubMed ID: 17275845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.